MBX Biosciences, Inc. (MBX)
28.68
-2.71
(-8.63%)
USD |
NASDAQ |
Dec 09, 16:00
28.75
+0.07
(+0.24%)
After-Hours: 06:05
MBX Biosciences Total Liabilities (Quarterly): 12.54M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Johnson & Johnson | 113.54B |
| Merck & Co., Inc. | 77.64B |
| Madrigal Pharmaceuticals, Inc. | 736.72M |
| Insmed, Inc. | 1.415B |
| Ionis Pharmaceuticals, Inc. | 2.415B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 400.08M |
| Shareholders Equity (Quarterly) | 387.54M |
| Debt to Equity Ratio | 0.0016 |
| Current Ratio | 32.95 |
| Net Debt Paydown Yield | -0.01% |